ARFFX | JVMRX | ARFFX / JVMRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 13 years | - |
Gain YTD | 0.185 | 2.079 | 9% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 66.9M | 22.5B | 0% |
Annual Yield % from dividends | 1.40 | 0.93 | 150% |
Returns for 1 year | 12.84 | -1.71 | -751% |
Returns for 3 years | 3.56 | 4.02 | 89% |
Returns for 5 years | 26.55 | 25.72 | 103% |
Returns for 10 years | 25.63 | 38.31 | 67% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HERFX | 10.33 | -0.01 | -0.10% |
Hartford Emerging Markets Equity F | |||
RYOAX | 55.26 | -0.20 | -0.36% |
Rydex Biotechnology H | |||
EPLCX | 22.30 | -0.19 | -0.84% |
NYLI Epoch U.S. Equity Yield Class I | |||
RMFFX | 57.89 | -0.62 | -1.06% |
American Funds American Mutual R5 | |||
GCTSX | 47.13 | -1.02 | -2.12% |
Goldman Sachs US Tax-Managed Eq Svc |